FDA.reportPublic FDA data

mepolizumab 100 MG Injection [Nucala]

RxCUI
1720606
RxNorm name
mepolizumab 100 MG Injection [Nucala]
Display name
mepolizumab 100 MG Injection [Nucala]
Full name
mepolizumab 100 MG Injection [Nucala]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:30

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125526Nucalamepolizumab351(a)Rx2026-10-01
761122Nucalamepolizumab351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fefb887c-e4ac-431e-8893-e9d1a5a63feaNucala 100 MG Injection [PSN] · mepolizumab 100 MG Injection [Nucala] [SBD] · Nucala 100 MG Injection [SY]324These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 201520250806